Structures by: Gumbau-Brisa R.
Total: 19
N-(2-{3-(benzyloxy)-2-methyl-4-oxopyridin-1(4H)-yl}ethyl)-2-methylprop-2-enamide
C19H22N2O3
MedChemComm (2018) 9, 7 1206-1212
a=7.24927(18)Å b=12.5565(3)Å c=19.2992(5)Å
α=90° β=90° γ=90°
C12H16N2O3,H2O
C12H16N2O3,H2O
MedChemComm (2018) 9, 7 1206-1212
a=7.13370(10)Å b=25.5550(5)Å c=7.17780(10)Å
α=90° β=101.3314(7)° γ=90°
C52H38Fe2N10O5
C52H38Fe2N10O5
CrystEngComm (2016) 18, 11 1892
a=13.0767(8)Å b=13.4441(8)Å c=14.3843(8)Å
α=100.563(2)° β=107.325(2)° γ=98.963(3)°
[6-(2'-Hydroxyphenyl)-6,7-dihydro-5H-dipyrido[3,2-d:2',3'-f][1,3]diazepine][salicylaldehydo]copper(II) perchlorate dimer methanol solvate
C49H42Cl2Cu2N8O15
CrystEngComm (2016) 18, 11 1892
a=15.2508(10)Å b=23.2887(16)Å c=12.9853(8)Å
α=90.00° β=90.00° γ=90.00°
[6-(2'-Hydroxyphenyl)-6,7-dihydro-5H-dipyrido[3,2-d:2',3'-f][1,3]diazepine]manganese(II)dichloride dimer
C38H40Cl4Mn2N8O4
CrystEngComm (2016) 18, 11 1892
a=9.4410(5)Å b=10.9557(6)Å c=10.9598(6)Å
α=64.848(3)° β=88.440(4)° γ=72.810(3)°
E,E-N3,N3'-Bis(2-hydroxybenzylidene)-(2,2'-bipyridine)-3,3'-diamine
C24H18N4O2
CrystEngComm (2016) 18, 11 1892
a=8.2616(5)Å b=11.0442(7)Å c=11.8712(7)Å
α=69.313(4)° β=76.743(4)° γ=71.691(4)°
[Bis(2-(3!-amino-2,2-bipyridin-3-imino)phenoxide)iron(III)] chlorideacetonitrile solvate
C38H32ClFeN10O2
CrystEngComm (2016) 18, 11 1892
a=13.163(3)Å b=19.772(5)Å c=13.268(2)Å
α=90.00° β=92.198(7)° γ=90.00°
[6-(2'-Hydroxyphenyl)-6,7-dihydro-5H-dipyrido[3,2-d:2',3'-f][1,3]diazepine]tin(iV) tetrachloride.2C2H5OH
C21H26Cl4N4O3Sn
CrystEngComm (2016) 18, 11 1892
a=8.3486(14)Å b=27.473(5)Å c=11.3936(17)Å
α=90.00° β=93.665(4)° γ=90.00°
0.8(C26H14N2S8),0.4(C13H7NS4)
0.8(C26H14N2S8),0.4(C13H7NS4)
CrystEngComm (2014) 16, 31 7268
a=11.274(2)Å b=8.2761(17)Å c=27.958(6)Å
α=90° β=95.47(3)° γ=90°
C26H14N2S8
C26H14N2S8
CrystEngComm (2014) 16, 31 7268
a=11.119(2)Å b=8.3345(17)Å c=28.069(6)Å
α=90.00° β=95.85(3)° γ=90.00°
C12H6N2S4
C12H6N2S4
CrystEngComm (2014) 16, 31 7268
a=3.9337(4)Å b=11.3951(9)Å c=27.644(2)Å
α=90° β=91.393(5)° γ=90°
0.8(C26H14N2S8),0.4(C13H7NS4)
0.8(C26H14N2S8),0.4(C13H7NS4)
CrystEngComm (2014) 16, 31 7268
a=11.274(2)Å b=8.2761(17)Å c=27.958(6)Å
α=90° β=95.47(3)° γ=90°
C26H14N2S8
C26H14N2S8
CrystEngComm (2014) 16, 31 7268
a=11.119(2)Å b=8.3345(17)Å c=28.069(6)Å
α=90.00° β=95.85(3)° γ=90.00°
C12H6N2S4
C12H6N2S4
CrystEngComm (2014) 16, 31 7268
a=3.9337(4)Å b=11.3951(9)Å c=27.644(2)Å
α=90° β=91.393(5)° γ=90°
E,E-N3,N3'-Bis(2-pyridylmethylene)-(2,2'-bipyridine)-3,3'-diamine
C22H16N6
CrystEngComm (2015) 17, 5 1159
a=10.9614(6)Å b=20.1743(11)Å c=8.7356(5)Å
α=90.00° β=101.490(3)° γ=90.00°
6-(2'-Pyridyl)-6,7-dihydro-5H-dipyrido[3,2-d:2',3'-f][1,3]diazepine
C16H13N5
CrystEngComm (2015) 17, 5 1159
a=9.8020(15)Å b=11.0335(17)Å c=12.7221(15)Å
α=87.172(7)° β=84.520(7)° γ=85.678(7)°
[6-(2'-Pyridyl)-6,7-dihydro-5H-dipyrido[3,2-d:2',3'-f][1,3]diazepine] copper(II)(hfac)(triflate)
C23H14CuF9N5O4
CrystEngComm (2015) 17, 5 1159
a=8.2407(9)Å b=10.3017(11)Å c=15.4495(16)Å
α=103.709(12)° β=98.082(12)° γ=101.143(13)°
N3,N3-Bis(Methoxy(pyridin-2-yl)methyl)-2,2-bipyridine-3,3-diamine
C24H24N6O2
CrystEngComm (2015) 17, 5 1159
a=4.9022(6)Å b=13.8842(15)Å c=15.385(2)Å
α=90.00° β=99.095(16)° γ=90.00°
[5-(2'-Pyridinoyl)-6-(pyrid-2-yl)-5H-dipyrido[3,2-d:2',3'-f][1,3]diazepine] complex with Zn(hfac)2
C32H16F12N6O5Zn
CrystEngComm (2015) 17, 5 1159
a=9.5227(8)Å b=12.9131(11)Å c=13.7732(11)Å
α=80.759(10)° β=80.757(10)° γ=84.987(10)°